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Malaria has become an emerging infection in Greece, which is the doorstep to Europe for thousands of immigrants.
With increasing immigration, cases with evidence of domestic transmission (autochthonous) are being reported. In
the present study, an isolate of Plasmodium vivax from an autochthonous clinical case was subjected to
phylogenetic analysis of the genes encoding the merozoite surface protein 1 (MSP-1) and the circumsporozoite
protein (CSP). In the MSP region, the strain was related with strains from Brazil, South Korea, Turkey and Thailand,
whereas in the CSP region, with strains from Brazil, Colombia and New Guinea. The present study establishes for
the first time in Greece the basis for the creation of a database comprising genotypic and phylogenetic
characteristics of Plasmodium spp.
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In 1974, Greece was officially declared as “malaria free”
and until 2008 only imported cases were notified. How-
ever in 2009, with increasing immigration, isolates with
evidence of domestic transmission (autochthonous) were
reported from Hellenic Center for Disease Control and
Prevention [1]. This study presents a recent autochthon-
ous case of Plasmodium vivax malaria in a Greek woman
from East Attica. The isolated Plasmodium strain was
phylogenetically analysed in order to establish a database
as a tool for further epidemiological monitoring.Case presentation
Clinical data
The patient, a 44 year-old woman, and a permanent
resident in Markopoulo, a city in East Attica (Figure 1),
was admitted on 11 July, 2012 to the outpatient department
of the private hospital Athens Medical Center- Peristeri,
with high fever (39°C) for the previous ten days, starting
with rigour. There was no history of previous travel abroad,* Correspondence: schatzipa@gmail.com
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reproduction in any medium, provided the orblood transfusion, tissue organ transplantation, intravenous
drug abuse or a prolonged febrile illness over the last year.
Heart and abdomen examinations were normal. Blood
cultures (six) were negative. The haematological exami-
nation revealed a progressively aggravating pancytopaenia.
The serological viral and bacterial investigations for EBV,
CMV, adenovirus, parvovirus, coxsackie, HIV, Rickettsiae,
Chlamydia and spirochetes were negative. Chest computer
tomography (CT) was normal. CT of the lower abdomen
showed a mild splenomegaly (about 15 cm). Transthoracic
echocardiograph, breast ultrasound (required because of
the family history reporting breast cancer of her mother
and sister) and MRI (including angiography) of the brain
were normal and could not justify the fever attacks. PCR
for Leishmania was negative. Microscopic examination of
thick and thin blood smears, performed eight days after
admission, was positive for P. vivax. The result was also
confirmed by PCR, and then several blood samples were
sent to special laboratories for further molecular processing.
The patient was successfully treated, initially with
atovaquone/proguanil (Malarone®, 1 g atovaquone /400 mg
proguanil total daily dose, referring to four tablets as a
single dose) for three consecutive days and then for 14 daysal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Map of Attica showing the city of Markopoulo where the autochthonous malaria case was isolated.
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G6PDH deficiency).
Consent
Ethical approval and patient consent was not required
for the study and the samples taken were part of the
standard patient care.
Phylogenetic analysis
Phylogenetic analysis of the isolated strain, as well as
from Plasmodium strains from worldwide composed
databases, was performed with respect to the highly poly-
morphic genes encoding the merozoite surface protein 1
(MSP-1) and the circumsporozoite protein (CSP) [2,3].
MSP-1 is a 200-kDa protein expressed on the surface
of the P. vivax merozoite, plays a key role during erythro-
cyte invasion and is a target of host protective immune
response [4]. Disruption of the Plasmodium msp-1 gene
has been demonstrated to have a deleterious effect on the
parasite growth in experimental animals [5]. MSP-1 is a
valuable polymorphic marker, organized into several
variable blocks, flanked by ten conserved sections and
having a dimorphic pattern [6]. Block 5, the region
encompassed by the interspecies conserved block ICB5
and ICB6, shows a dimorphic pattern of sequences thathave little homology. These patterns are mainly composed
of three major types (Sal-I, Belem, and Recombinant) and
their subtypes [2,6]. CSP covers the surface of infectious
sporozoites involved in the sporozoite invasion of hepato-
cytes and has been considered an important vaccine candi-
date [7]. The central repetitive domain from the CSP varies
in sequence and length among Plasmodium spp. The
classic P. vivax VK210 strain has CSP amino sequence
that includes a GDRAA/DGQPA repeat [8]. A variant
form, VK247, later identified in Thailand, possesses an
ANGAGNQPG amino acid repeat within the amino acid
tandem repeat region [9]. All CSP variant genotypes
have a worldwide distribution [10,11]. This polymorphic
marker was useful for genetic epidemiological surveys
where P. vivax is endemic.
For phylogenetic analysis, the P. vivax genes for MSP-1
and the CSP were first PCR amplified and sequenced.
DNA was extracted from 200 μl of patient blood using the
QIAamp DNA Blood Mini kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Primer se-
quences for the amplification of the DNA fragment
encompassing the csp gene and the ICB5-ICB6 region of
the msp-1 gene were adopted from previous reports [2].
Optimization of the above PCR assays for the primers
concentration, as well as for the annealing temperature,
Figure 2 Neighbour-joining tree of Plasmodium vivax merozoite surface protein-1. A. MSP-1 gene sequences from the strain obtained from
Greece, as well as from the GenBank. B. Subtree including the Greek strain and depicting its phylogenetic relationship with other strains. Bullets
represent >75% bootstrap value (1,000 replicates).
Figure 3 Neighbour-joining tree of Plasmodium vivax circumsporozoite protein. A. CSP gene sequences from the strain obtained from
Greece, as well as from the GenBank. B. Subtree including the Greek strain and depicting its phylogenetic relationship with other strains. Bullets
represent >75% bootstrap value (1,000 replicates).
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Mix, 2× (Promega, Madison, WI, USA) on a Eppendorf
Mastercycler gradient thermal cycler.
The PCR resulting amplicons were purified utilizing the
QIAquick PCR purification kit (Qiagen, Hilden, Germany)
and the MinEluteTM gel extraction kit (Qiagen, Hilden,
Germany) and sequenced in both directions using the
GenomeLab DTCS-quick start sequencing kit (Beckman
Coulter, Brea, CA, USA) on a CEQTM 8000 genetic
analyzer (Beckman Coulter, USA).
For the genetic comparison and the phylogenetic analysis,
the P. vivax gene sequences amplified from the malaria
patient’s blood specimen were compared with previously
published P. vivax msp-1 and csp gene sequences on
GenBank of National Center for Biotechnology Informa-
tion. Sequences from the patient have been deposited
in the GenBank database under the accession numbers
KC682100 for msp-1 and KC896384 for csp genes.
Multiple sequence alignment of all the gene sequences
and loci was performed with the algorithm Clustal W
using the MEGA (Molecular Evolutionary Genetics
Analysis) 5.05 software. Alignments were manually
edited and insertions/deletions in coding regions were
determined from multiple alignments of amino acid
sequences to maintain the reading frame. Genetic distances
between the sequences were calculated using the Tamura-
Nei model [12,13]. Phylogenetic trees were constructed
using the neighbour-joining method and their reliability
was tested by bootstrapping analysis (1,000 replicates). One
cluster was considered significant if it was present in more
than 75% of the permuted trees.
Conclusions
Phylogenetic analysis in the MSP region showed that the
investigated strain was related with strains from Brazil,
South Korea, Turkey and Thailand (Figure 2A and B),
whereas in the CSP region it clustered with strains from
Brazil, Colombia and New Guinea (Figure 3A and B).
Taking into consideration previously published studies
[2,6,8-11,14], the amino acid sequence was in the MSP
and CSP regions with reference isolates. Regarding the
MSP region, the strain belonged to the Belem type,
whereas with respect to the CSP region, to the VK210
type (alignment not shown). The obvious discrepancy
between the results of the phylogenetic analysis in the
MSP and CSP regions is due to the absence of adequate
Plasmodium sequence data at the GenBank database and
to the absence of adequate number of paired sequences
from the same strain [14]. However, using msp1 and csp
as genetic markers, the close proximity of the strain in
both regions with strains from South America in both
trees (Brazil, Colombia) denotes a possible origin of the
Plasmodium strain from South America. Further studies,
including isolates of autochthonous cases, will be requiredin order to obtain a clearer picture of Plasmodium diver-
sity in Greece.
The present study establishes, for the first time in Greece
the basis for the creation of a database comprising
genotypic and phylogenetic characteristics of Plasmodium
spp. Malaria has become an emerging infection in Greece,
which is the doorstep to Europe for thousands of immi-
grants. Therefore clinicians should be aware of considering
malaria early in their differential diagnosis. The enrichment
in the future with new strains of imported and autochtho-
nous cases will be an invaluable tool for the epidemiological
monitoring of malaria in Europe.
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